BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND FANCA, MGC75158, 2175, ENSG00000187741, FA-H, FA, FAA, FANCH, FA1, FACA AND Prognosis
43 results:

  • 1. Diagnostic and prognostic utility of TROP-2, SLP-2, and CXCL12 expression in papillary thyroid carcinoma.
    Attia AS; Hussein S; Sameh H; Khalil A; Waley AB; Matar I; Sameh R
    Cancer Biomark; 2024; 39(3):211-221. PubMed ID: 38073379
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Identification of Diagnostic Metabolic Signatures in Thyroid Tumors Using Mass Spectrometry Imaging.
    Mao X; Huang L; Li T; Abliz Z; He J; Chen J
    Molecules; 2023 Jul; 28(15):. PubMed ID: 37570761
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Can Preoperative Diffusion Tensor Imaging Tractography Predict the Visual Outcomes of Patients with Pituitary Macroadenomas? A Prospective Pilot Study.
    Mohamadzadeh O; Sadrehosseini SM; Tabari A; Ghanaati H; Zeinalizadeh M
    World Neurosurg; 2023 Apr; 172():e326-e334. PubMed ID: 36640834
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. An Acid Response IR780-Based Targeted Nanoparticle for Intraoperative Near-Infrared Fluorescence Imaging of Ovarian cancer.
    Song J; Ye H; Jiang S; Yang Y; Li X
    Int J Nanomedicine; 2022; 17():4961-4974. PubMed ID: 36275480
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prognostic factors and mitotane treatment of adrenocortical cancer. Two decades of experience from an institutional case series.
    Tőke J; Uhlyarik A; Lohinszky J; Stark J; Huszty G; Micsik T; Borka K; Reismann P; Horányi J; Igaz P; Tóth M
    Front Endocrinol (Lausanne); 2022; 13():952418. PubMed ID: 36246926
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Update regarding the role of PD-L1 in oncocytic thyroid lesions on cytological samples.
    Dell'Aquila M; Tralongo P; Granitto A; Martini M; Capodimonti S; Curatolo M; Fiorentino V; Pontecorvi A; Fadda G; Lombardi CP; Raffaelli M; Pantanowitz L; Larocca LM; Rossi ED
    J Clin Pathol; 2023 Oct; 76(10):671-677. PubMed ID: 35701142
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Folic Acid-Modified Fluorescent-Magnetic Nanoparticles for Efficient Isolation and Identification of Circulating Tumor Cells in Ovarian cancer.
    Pan Y; Wang Z; Ma J; Zhou T; Wu Z; Ding P; Sun N; Liu L; Pei R; Zhu W
    Biosensors (Basel); 2022 Mar; 12(3):. PubMed ID: 35323454
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Folate-mediated targeted PLK1 inhibition therapy for ovarian cancer: A comparative study of molecular inhibitors and siRNA therapeutics.
    Wang Z; Zhao S; Shi J; Meng F; Yuan J; Zhong Z
    Acta Biomater; 2022 Jan; 138():443-452. PubMed ID: 34757229
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Systemic Therapy for Metastatic Pancreatic cancer.
    Ettrich TJ; Seufferlein T
    Curr Treat Options Oncol; 2021 Oct; 22(11):106. PubMed ID: 34665339
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Long noncoding RNA landscapes specific to benign and malignant thyroid neoplasms of distinct histological subtypes.
    Yakushina VD; Strelnikov VV; Tanas AS; Lavrov AV
    Sci Rep; 2021 Aug; 11(1):16728. PubMed ID: 34408227
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Targeting Glutathione and Cystathionine β-Synthase in Ovarian cancer Treatment by Selenium-Chrysin Polyurea Dendrimer Nanoformulation.
    Santos I; Ramos C; Mendes C; Sequeira CO; Tomé CS; Fernandes DGH; Mota P; Pires RF; Urso D; Hipólito A; Antunes AMM; Vicente JB; Pereira SA; Bonifácio VDB; Nunes SC; Serpa J
    Nutrients; 2019 Oct; 11(10):. PubMed ID: 31635026
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The diagnostic significance of trophoblast cell-surface antigen-2 expression in benign and malignant thyroid lesions.
    Sadullahoğlu C; Sayıner A; Süren D; Yıldırım HT; Nergiz D; Sezer C; Oruç MT
    Indian J Pathol Microbiol; 2019; 62(2):206-210. PubMed ID: 30971541
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Quantitative assessment of secondary white matter injury in the visual pathway by pituitary adenomas: a multimodal study at 7-Tesla MRI.
    Rutland JW; Padormo F; Yim CK; Yao A; Arrighi-Allisan A; Huang KH; Lin HM; Chelnis J; Delman BN; Shrivastava RK; Balchandani P
    J Neurosurg; 2019 Jan; 132(2):333-342. PubMed ID: 30660127
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Comprehensive Transcriptomic and Genomic Profiling of Subtypes of Follicular Variant of Papillary Thyroid Carcinoma.
    Song YS; Won JK; Yoo SK; Jung KC; Kim MJ; Kim SJ; Cho SW; Lee KE; Yi KH; Seo JS; Park YJ
    Thyroid; 2018 Nov; 28(11):1468-1478. PubMed ID: 30226444
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Preparation of Folic Acid-Targeted Temperature-Sensitive Magnetoliposomes and their Antitumor Effects In Vitro and In Vivo.
    Wang X; Yang R; Yuan C; An Y; Tang Q; Chen D
    Target Oncol; 2018 Aug; 13(4):481-494. PubMed ID: 29992403
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Diagnostic utility of DREAM gene mRNA levels in thyroid tumours.
    Batista FA; Marcello MA; Martins MB; Peres KC; Cardoso UO; Silva ACDN; Bufalo NE; Soares FA; Silva MJD; Assumpção LV; Ward LS
    Arch Endocrinol Metab; 2018; 62(2):205-211. PubMed ID: 29641740
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Folic Acid Targeting for Efficient Isolation and Detection of Ovarian cancer CTCs from Human Whole Blood Based on Two-Step Binding Strategy.
    Nie L; Li F; Huang X; Aguilar ZP; Wang YA; Xiong Y; Fu F; Xu H
    ACS Appl Mater Interfaces; 2018 Apr; 10(16):14055-14062. PubMed ID: 29620849
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Visual Outcome of an Endoscopic Endonasal Transsphenoidal Approach in Pituitary Macroadenomas: Quantitative Assessment with Diffusion Tensor Imaging Early and Long-Term Results.
    Anik I; Anik Y; Cabuk B; Caklili M; Pirhan D; Ozturk O; Cirak M; Ceylan S
    World Neurosurg; 2018 Apr; 112():e691-e701. PubMed ID: 29408649
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Identification of Two Distinct Molecular Subtypes of Non-Invasive Follicular Neoplasm with Papillary-Like Nuclear Features by Digital RNA Counting.
    Giannini R; Ugolini C; Poma AM; Urpì M; Niccoli C; Elisei R; Chiarugi M; Vitti P; Miccoli P; Basolo F
    Thyroid; 2017 Oct; 27(10):1267-1276. PubMed ID: 28679352
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. HLA-G 3' untranslated region polymorphic sites associated with increased HLA-G production are more frequent in patients exhibiting differentiated thyroid tumours.
    de Figueiredo-Feitosa NL; Martelli Palomino G; Cilião Alves DC; Mendes Junior CT; Donadi EA; Maciel LM
    Clin Endocrinol (Oxf); 2017 Apr; 86(4):597-605. PubMed ID: 27914217
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.